Leucocyte telomere length and paroxysmal atrial fibrillation: A prospective cohort study and systematic review with meta-analysis
- PMID: 29943516
- PMCID: PMC6816961
- DOI: 10.1002/jcla.22599
Leucocyte telomere length and paroxysmal atrial fibrillation: A prospective cohort study and systematic review with meta-analysis
Abstract
Background: Telomere length is a surrogate marker of biological aging. Whether telomere length predicts the risk of atrial fibrillation (AF) independently of biological aging is controversial. We conducted a cohort study to examine the relationship between telomere length and paroxysmal AF (PAF), followed by a systematic review and meta-analysis of the published literature, incorporating our own data.
Methods: DNA was extracted from peripheral blood. Leucocyte telomere length was measured by a real-time polymerase chain reaction-based method, normalized to a single copy gene, and presented as telomere/single gene ratio (t/s).
Results: A total of 100 non-AF patients and 50 PAF patients (mean age: 61.0 ± 9.4 and 64.0 ± 10.7 years, respectively) were included. T/s for subjects without AF tended to be shorter than for those with AF (0.21 [0.06-0.36] vs 0.28 [0.11-0.71], P = .077). T/s was associated with a 1.60-fold increase in the risk of AF but this was not significant (95% CI: 0.988-2.597, P = .056). Our meta-analysis confirms no difference in telomere length between AF and non-AF patients and t/s was not associated with higher risk of AF in multivariate analysis.
Conclusions: Our prospective data showed that leucocyte telomere length was similar between AF and non-AF patients but was significantly longer in male patients with PAF than those without AF in our subgroup analysis. Our meta-analysis found that t/s did not predict AF. These findings support the notion that chronological aging, but not markers of biological aging, predicts the risk of AF.
Keywords: atrial fibrillation; telomere length; telomere/single gene ratio.
© 2018 Wiley Periodicals, Inc.
Figures






References
-
- Carlquist JF, Knight S, Cawthon RM, et al. Shortened telomere length is associated with paroxysmal atrial fibrillation among cardiovascular patients enrolled in the Intermountain Heart Collaborative Study. Heart Rhythm. 2016;13:21‐27. - PubMed
-
- Lloyd‐Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042‐1046. - PubMed
-
- Allende M, Molina E, Gonzalez‐Porras JR, Toledo E, Lecumberri R, Hermida J. Short leukocyte telomere length is associated with cardioembolic stroke risk in patients with atrial fibrillation. Stroke. 2016;47:863‐865. - PubMed
-
- Sawhney V, Campbell NG, Brouilette SW, et al. Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients ‐ Potential markers of ventricular arrhythmia. Int J Cardiol. 2016;207:157‐163. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical